Biotech Startup Hopes to Cure Cancer with Artificial Intelligence

Imagine devoting fifteen years to an important pursuit and pouring unbelievable amounts of money into it, all the while facing a failure rate of 95 percent. That’s the disheartening reality for pharmaceutical companies, which throw billions of dollars every year toward drugs that likely will not work – and then go back to the drawing board and do it all over again. There has to be a better way. That’s where Berg comes in. Backed by billionaire real estate magnate Carl Berg, the promising biotech startup founded in 2006, and has since seen great strides toward a new type of drug creation process. It’s cheaper and much faster, thanks to artificial intelligence. The Cumbersome Drug Discovery Process Today’s drugs come to the market after a lengthy, quite expensive process. It…


Link to Full Article: Biotech Startup Hopes to Cure Cancer with Artificial Intelligence